News
PreciDIAB is the National Center for Precision Medicine for diabetes, bringing together leading scientists and multidisciplinary clinicians from Lille and Amiens, players in the health industry and innovative start-ups, and associations of patients and professionals. The whole project is also strongly supported by national and local authorities with total funding to date of 23M € (2020-2025).
PreciDIAB’s mission is simple but ambitious: to offer by 2025 new solutions to prevent and treat all diabetes and their complications, and to allow people with diabetes to have an expectation and a quality of life identical to that of non-diabetic, all at a controlled cost.
A holistic approach based on 4 pillars for personalized patient care :
Innovation & Personalized Medicine through the development of public-private partnerships
Translational research
in order to understand the physiopathological mechanisms at the heart of the different forms of diabetes
Clinical research
to elucidate the key mechanisms of the development of complications associated with diabetes and thus propose innovative methods of prevention and personalized treatment
the exploitation of results
through innovation and technology transfer through the industrial club PreciDIAB Initiative
education, training
and dissemination of knowledge resulting from PreciDIAB research
- translational research in order to understand the physiopathological mechanisms at the heart of the different forms of diabetes
- clinical research to elucidate the key mechanisms of the development of complications associated with diabetes and thus propose innovative methods of prevention and personalized treatment
- the exploitation of results through innovation and technology transfer through the industrial club PreciDIAB Initiative
- of knowledge resulting from PreciDIAB research
Based on these 4 pillars, PreciDIAB offers a program that revolves around several projects for the prevention of obesity, diabetes and its comorbidities, especially in high-risk people (obese children, mothers with gestational diabetes). , precarious people), as well as in complex patients combining other types of pathologies (cardiac, cerebral, renal). These prevention programs will be combined with the development of precision medicine based on the stratification of patients through biological, genetic and environmental markers. The stated objective is to change the paradigm of care for all people with diabetes or at risk of becoming so, in order to prevent or delay the onset of diabetes and their complications throughout life, to birth to senescence.
In order to strengthen the attractiveness on the territory and to structure public-private partnership projects in an open innovation approach, the industrial club of PreciDIAB – PreciDIAB Initiative – is a driving force for the development of partnerships with companies, entrepreneurs and investors working on all diabetes issues. The club is also a place of exchange aimed at generating new projects between academic teams and industrial players.
